Development and validation of an in vitro model to study thrombin generation on the surface of catheters in platelet-poor and platelet-rich plasma

Autor: Hardy, M., Douxfils, J., Xhaet, O., Robaye, B., Lessire, S., Lecompte, T., Mullier, F.

Publikováno v: In Thrombosis Research December 2024 244

Biological variation of thrombin generation on ST Genesia.

Autor: van Dievoet MA; Hematology Department of Laboratory Medicine, Saint-Luc University Hospital, Brussels, Belgium., Morimont L; Department of Pharmacy, Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.; QUALIblood s.a., Namur, Belgium., Bouvy C; Department of Pharmacy, Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.; QUALIblood s.a., Namur, Belgium., Gruson D; Biochemistry Department of Laboratory Medicine, Saint-Luc University Hospital, Brussels, Belgium., Stephenne X; Pediatric Hepatology and Gastroenterology, Cliniques Universitaires Saint-Luc, Brussels, Belgium., Douxfils J; Department of Pharmacy, Faculty of Medicine, Namur Research Institute for Life Sciences (NARILIS), University of Namur, Namur, Belgium.; QUALIblood s.a., Namur, Belgium.; Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France.

Publikováno v: International journal of laboratory hematology [Int J Lab Hematol] 2024 Jun; Vol. 46 (3), pp. 564-567. Date of Electronic Publication: 2024 Jan 22.

Neutralizing antibodies against KP.2 and KP.3: why the current vaccine needs an update.

Autor: Gillot C; Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium., David C; Research and Development Department, Qualiblood s.a., Namur, Belgium., Dogné JM; Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium., Cabo J; Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium., Douxfils J; Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium.; Research and Development Department, Qualiblood s.a., Namur, Belgium.; Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France., Favresse J; Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences, Namur Thrombosis and Hemostasis Center, University of Namur, Namur, Belgium.; Department of Laboratory Medicine, Clinique St-Luc Bouge, Namur, Belgium.

Publikováno v: Clinical chemistry and laboratory medicine [Clin Chem Lab Med] 2024 Aug 16. Date of Electronic Publication: 2024 Aug 16.

Letter to the Editor: Efficacy and safety of fezolinetant for vasomotor symptoms in postmenopausal women: A systematic review and meta-analysis of randomized controlled trials.

Autor: Douxfils J; Department of Pharmacy, Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Namur, Belgium.; QUALIblood sa, Namur, Belgium.; Department of Biological Hematology, CHU Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France., Beaudart C; Department of Biomedical Sciences, Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Namur, Belgium.; WHO Collaborating Center for Epidemiology of Musculoskeletal Health and Aging Division of Public Health, Epidemiology and Health Economics, University of Liège, Liège, Belgium., Dogné JM; Department of Pharmacy, Research Unit in Clinical Pharmacology and Toxicology, Namur Research Institute for Life Sciences (NARILIS), Faculty of Medicine, University of Namur, Namur, Belgium.

Publikováno v: International journal of gynaecology and obstetrics: the official organ of the International Federation of Gynaecology and Obstetrics [Int J Gynaecol Obstet] 2024 Aug; Vol. 166 (2), pp. 905-906. Date of Electronic Publication: 2024 Jun 16.

Lower reporting of venous thromboembolisms events with natural estrogen-based combined oral contraceptives compared to ethinylestradiol-containing pills: A disproportionality analysis of the Eudravigilance database.

Autor: Didembourg M; Qualiblood sa, QUALIresearch, Namur, Belgium; University of Namur, Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium., Locquet M; University of Namur, Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium., Raskin L; University of Namur, Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium., Tchimchoua BT; University of Namur, Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium., Dogné JM; University of Namur, Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium., Beaudart C; University of Namur, Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium., Douxfils J; Qualiblood sa, QUALIresearch, Namur, Belgium; University of Namur, Clinical Pharmacology and Toxicology Research Unit, Namur Research Institute for Life Sciences (NARILIS), Namur, Belgium; Department of Biological Hematology, Centre Hospitalier Universitaire Clermont-Ferrand, Hôpital Estaing, Clermont-Ferrand, France. Electronic address: jonathan.douxfils@unamur.be.

Publikováno v: Contraception [Contraception] 2024 Oct 17, pp. 110727. Date of Electronic Publication: 2024 Oct 17.